Reuters logo
BRIEF-Regeneron Pharmaceuticals say CEO Leonard Schleifer's 2016 total compensation was $28.3 mln - SEC filing
2017年4月25日 / 中午11点41分 / 5 个月前

BRIEF-Regeneron Pharmaceuticals say CEO Leonard Schleifer's 2016 total compensation was $28.3 mln - SEC filing

April 25 (Reuters) - Regeneron Pharmaceuticals Inc

* Regeneron Pharmaceuticals Inc - CEO Leonard Schleifer’s 2016 total compensation was $28.3 million versus $47.5 million - SEC filing

* Regeneron Pharmaceuticals Inc - CFO Robert Landry’s 2016 total compensation was $5.2 million versus $8.2 million - SEC filing

* Regeneron Pharmaceuticals Inc - President George Yancopoulos's total compensation in 2016 was $27.77 million versus $40.30 million Source text: (bit.ly/2pdwfOv) Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below